Metabolites
Displaying compounds 2051 - 2075 of 16042 in total
| YMDB ID | Name CAS Number | IUPAC Name | Formula Weight | Structure |
|---|---|---|---|---|
| YMDB14087 | PE(10:0/18:0) | (2-aminoethoxy)[(2R)-3-(decanoyloxy)-2-(octadecanoyloxy)propoxy]phosphinic acid | C33H66NO8P 635.864 | |
| YMDB13859 | PE-NMe(12:0/15:0) | [3-(dodecanoyloxy)-2-(pentadecanoyloxy)propoxy][2-(methylamino)ethoxy]phosphinic acid | C33H66NO8P 635.864 | |
| YMDB15596 | TG(10:0/10:0/16:1(9Z)) | (2S)-2,3-bis(decanoyloxy)propyl (9Z)-hexadec-9-enoate | C39H72O6 636.999 | |
| YMDB15597 | TG(10:0/12:0/14:1(9Z)) | (2S)-3-(decanoyloxy)-2-(dodecanoyloxy)propyl (9Z)-tetradec-9-enoate | C39H72O6 636.999 | |
| YMDB12894 | DG(15:1(9Z)/22:0/0:0) | (2R)-1-hydroxy-3-[(9Z)-pentadec-9-enoyloxy]propan-2-yl docosanoate | C40H76O5 637.043 | |
| YMDB12705 | DG(10:0/26:1(9Z)/0:0) | (2R)-1-(decanoyloxy)-3-hydroxypropan-2-yl (10Z)-heptacos-10-enoate | C40H76O5 637.043 | |
| YMDB12829 | DG(15:0/22:1(11Z)/0:0) | (2R)-1-hydroxy-3-(pentadecanoyloxy)propan-2-yl (11Z)-docos-11-enoate | C40H76O5 637.043 | |
| YMDB12830 | DG(15:0/22:1(9Z)/0:0) | (2R)-1-hydroxy-3-(pentadecanoyloxy)propan-2-yl (9Z)-docos-9-enoate | C40H76O5 637.043 | |
| YMDB12861 | DG(15:1(11Z)/22:0/0:0) | (2R)-1-hydroxy-3-[(11Z)-pentadec-11-enoyloxy]propan-2-yl docosanoate | C40H76O5 637.043 | |
| YMDB15442 | PS(10:0/15:0) | (2S)-2-amino-3-({[(2R)-3-(decanoyloxy)-2-(pentadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)propanoic acid | C31H60NO10P 637.792 | |
| YMDB15595 | TG(12:0/12:0/12:0) | 1,3-bis(dodecanoyloxy)propan-2-yl dodecanoate | C39H74O6 639.0013 | |
| YMDB15593 | TG(10:0/10:0/16:0) | (2S)-2,3-bis(decanoyloxy)propyl hexadecanoate | C39H74O6 639.015 | |
| YMDB15594 | TG(10:0/12:0/14:0) | (2S)-3-(decanoyloxy)-2-(dodecanoyloxy)propyl tetradecanoate | C39H74O6 639.015 | |
| YMDB12828 | DG(15:0/22:0/0:0) | (2R)-1-hydroxy-3-(pentadecanoyloxy)propan-2-yl docosanoate | C40H78O5 639.059 | |
| YMDB00029 | ADP-D-ribose 1''-phosphate | {[(2R,3R,4S,5R)-5-[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-3,4-dihydroxyoxolan-2-yl]oxy}phosphonic acid | C15H24N5O17P3 639.2956 | |
| YMDB01737 | Malvidin 3-O-(coumaroylglucoside) | 5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)oxan-2-yl]oxy}-1λ⁴-chromen-1-ylium | C32H31O14 639.5801 | |
| YMDB01105 | Cer 18:0;3/22:0;0 | N-[(2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl]docosanamide | C40H81NO4 640.0754 | |
| YMDB15297 | PI(10:0/10:0) | [(2R)-2,3-bis(decanoyloxy)propoxy]({[(1s,3R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid | C29H55O13P 642.72 | |
| YMDB16180 | Phosphatidylinositol-3,4,5-trisphosphate | {[(1S,2S,3S,4S,5R,6S)-3-({[2,2-bis(acetyloxy)ethoxy](hydroxy)phosphoryl}oxy)-2,4-dihydroxy-5,6-bis(phosphonooxy)cyclohexyl]oxy}phosphonic acid | C12H24O22P4 644.2008 | |
| YMDB01164 | PA(16:1(9Z)/16:1(9Z)) | [(2R)-2,3-bis[(9Z)-hexadec-9-enoyloxy]propoxy]phosphonic acid | C35H65O8P 644.8596 | |
| YMDB13473 | PA(14:1(9Z)/18:1(9Z)) | [(2R)-2-[(9Z)-octadec-9-enoyloxy]-3-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphonic acid | C35H65O8P 644.871 | |
| YMDB13474 | PA(14:1(9Z)/18:1(11Z)) | [(2R)-2-[(11Z)-octadec-11-enoyloxy]-3-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphonic acid | C35H65O8P 644.871 | |
| YMDB13475 | PA(14:1(11Z)/18:1(9Z)) | [(2R)-2-[(9Z)-octadec-9-enoyloxy]-3-[(11Z)-tetradec-11-enoyloxy]propoxy]phosphonic acid | C35H65O8P 644.871 | |
| YMDB13476 | PA(14:1(11Z)/18:1(11Z)) | [(2R)-2-[(11Z)-octadec-11-enoyloxy]-3-[(11Z)-tetradec-11-enoyloxy]propoxy]phosphonic acid | C35H65O8P 644.871 | |
| YMDB13477 | PA(16:1(9Z)/16:1(11Z)) | [(2R)-2-[(11Z)-hexadec-11-enoyloxy]-3-[(9Z)-hexadec-9-enoyloxy]propoxy]phosphonic acid | C35H65O8P 644.871 |